This sets realistic timelines, helping reduce product abandonment, a common issue in which users stop too soon, missing out on benefits
This improvement is driven by an increase in average forecast peak sales per asset, which climbed to US$598 million in 2025, a notable jump from $510 million in 2024 (see Figure 2)
Bosk, J., Micenkov, L., Dolealov, M
Because fewer cardiovascular events occurred than anticipated, these analyses were not designed to establish cardiovascular benefit and should be interpreted cautiously
It is strictly prohibited for human consumption, and it is not meant for medical, veterinary, or household uses
Bariatric surgery volumes are declining for the first time in recorded history as GLP-1 pharmacotherapy outcomes approach surgical efficacy thresholds